about
Plant extracts inhibit ADP-induced platelet activation in humans: their potential therapeutic role as ADP antagonistsPerioperative management and monitoring of antiplatelet agents: a focused review on aspirin and P2Y12 inhibitorsP2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?Pharmacodynamic Effects When Clopidogrel is Given Before Cangrelor Discontinuation.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cangrelor: a novel P2Y12 receptor antagonist.
@en
Cangrelor: a novel P2Y12 receptor antagonist.
@nl
type
label
Cangrelor: a novel P2Y12 receptor antagonist.
@en
Cangrelor: a novel P2Y12 receptor antagonist.
@nl
prefLabel
Cangrelor: a novel P2Y12 receptor antagonist.
@en
Cangrelor: a novel P2Y12 receptor antagonist.
@nl
P2860
P1476
Cangrelor: a novel P2Y12 receptor antagonist.
@en
P2860
P304
P356
10.1517/13543780903136708
P407
P577
2009-08-01T00:00:00Z